Latest News

Pediatric hepatitis has not increased during pandemic: CDC


 

FROM MMWR


Investigators found no statistically significant increases in the outcomes during October 2021 to March 2022 versus pre-pandemic years:

  • Weekly ED visits with hepatitis-associated discharge codes
  • Hepatitis-associated monthly hospitalizations in children aged 0-4 years (22 vs. 19.5; P = .26)
  • Hepatitis-associated monthly hospitalization in children aged 5-11 years (12 vs. 10.5; P = .42)
  • Monthly liver transplants (5 vs. 4; P = .19)
  • Percentage of stool specimens positive for adenovirus types 40/41, though the number of specimens tested was highest in March 2022

The authors acknowledged that pediatric hepatitis is rare, so it may be difficult tease out small changes in the number of cases. Also, data on hospitalizations and liver transplants have a 2- to 3-month reporting delay, so the case counts for March 2022 “might be underreported,” they wrote. Mr. Kohli noted that because hepatitis and adenovirus are not reportable conditions, the analysis relied on retrospective data from insurance companies and electronic medical records. Retrospective data are inherently limited, compared with prospective analyses, he said, and it’s possible that certain cases could be included in more than one database and thus be double-counted, whereas other cases could be missed entirely.

These findings also conflict with data from the United Kingdom, which in May reported that the average number of hepatitis cases had increased, compared with previous years, he said. More data are needed, he said, and he is involved with a study with the North American Society for Pediatric Gastroenterology and the American Association for the Study of Liver Diseases that is also collecting data to try to understand whether there has been an uptick in pediatric hepatitis cases. The study will collect patient data directly from hospitals as well as include additional pathology data, such as biopsy results.

“We should not be inhibited to look further academically – and public health–wise – while we take into cognizance this very good, robust attempt from the CDC,” he said.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Children and COVID: Cases down, start of vaccinations near
Clinician Reviews
‘Medical maximizers’ dole out unneeded antibiotics for ASB
Clinician Reviews
People with HIV may need an additional COVID vaccine dose
Clinician Reviews
Current monkeypox outbreak marked by unconventional spread, clinical features
Clinician Reviews
Surprising link between herpes zoster and dementia
Clinician Reviews
Children and COVID: New cases hold steady in nonholiday week
Clinician Reviews
Nonhealing Violaceous Plaque of the Hand Following a Splinter Injury
Clinician Reviews
Is hepatitis C an STI?
Clinician Reviews
Blood test aims to measure COVID immunity
Clinician Reviews
WHO to rename monkeypox because of stigma concerns
Clinician Reviews